PDF
Cardiomyogenic differentiation of an induced pluripotent stem cell line carrying PRKAG2 R302Q mutation
Yi Gu1, Xiaocheng Lu1, Zuoren Yu1,2, Jian Yao3(
), Hongzhuan Sheng1()
PDF
Cardiomyogenic differentiation of an induced pluripotent stem cell line carrying PRKAG2 R302Q mutation
), Hongzhuan Sheng1()| 1 | M Calore. The PRKAG2 gene and hypertrophic cardiomyopathy: an energetically imbalanced relationship. Am J Physiol Heart Circ Physiol. 2017;313(2):H248-H250. |
| 2 | P Poyhonen, A Hiippala, L Ollila, et al. Cardiovascular magnetic resonance findings in patients with PRKAG2 gene mutations. J Cardiovasc Magn Reson. 2015;17: 89. |
| 3 | W Lu, H Sheng. Treatment of myocardial hypertrophy in patients with PRKAG2 cardiac syndrome. Chin J Heart Fail Cardiomyopathy. 2021;5(2):91-96. |
| 4 | C Sacchetto, L Vitiello, LJ de Windt, A Rampazzo, M Calore. Modeling cardiovascular diseases with hiPSC-derived cardiomyocytes in 2D and 3D cultures. Int J Mol Sci. 2020;21(9):3404. |
| 5 | Y Yoshida, S Yamanaka. Induced pluripotent stem cells 10 years later: for cardiac applications. Circ Res. 2017;120: 1958-1968. |
/
| 〈 |
|
〉 |
AI Summary
